LabCorp and Walgreens will create co-branded testing centers within seven Walgreens located in Denver, North Carolina, and Illinois.
Quest said that Walmart shoppers will get the diagnostic insights they need through the provision of laboratory testing and other healthcare services.
The collaboration will leverage DiaSorin's Liaion MDX PCR system, and Tecan's Fluent Laboratory Automation Solution to provide users a complete sample-to-result system.
Under the terms of the deal, MDxHealth and QUT will evaluate and develop the test, which will evaluate abnormal DNA methylation changes.
Under today's deal, all of UC Health's medical centers will work with GeneDx and have access to more than 400 of the firm's tests for rare hereditary disorders.
Biocartis and MRCT are planning to develop a range of molecular diagnostic assays for Biocartis' fully automated Idylla platform.
Xifin customers will be able to access lab services in support of consumer-initiated testing and employer-based screening programs, as part of the deal.
The collaborations will evaluate whether patient-specific ex vivo cancer immunotherapy assays can predict in vivo efficacy, and ACEA's cell analysis platform.
Each panel that the collaborators develop is expected to be highly multiplexed and syndromic, addressing clinically important infectious diseases in Asia.
The partners will combine the analysis of high-risk inherited genes and several hundred SNPs into a single NGS test for inherited cancer risk.